This bill proposes significant updates to the current statutes regarding the administration of abortion-inducing drugs. Under the new provisions, a qualified physician must conduct an in-person examination of the patient before providing the drug, which includes verifying pregnancy, determining blood type, informing the patient of potential side effects, and documenting specific medical details in the patient's chart. Additionally, the physician must be credentialed to manage complications or have a signed agreement with another qualified physician. The bill also mandates scheduling a follow-up visit to confirm the termination of pregnancy and assess bleeding, with documentation of efforts to ensure the patient returns for this appointment.

Furthermore, the bill establishes a civil right of action for individuals who are intentionally or knowingly harmed by violations of these requirements. This includes provisions for monetary damages, statutory damages, and attorney fees. It also outlines confidentiality measures for the identity of women involved in such actions and specifies that no civil action can be brought against the woman who received the abortion-inducing drug. The legislation emphasizes that it does not create or recognize a right to abortion and includes a severability clause to maintain the validity of other provisions if any part is deemed invalid.

Statutes affected:
Introduced Version: 36-2160
House Engrossed Version: 36-2160